Notably, we find that SH3BP5 promotes the growth and survival of human AML cells, and c-Jun N-terminal kinases- Bcl-2 associated agonist of cell death (JNK-BAD) signaling is suppressed upon SH3BP5 knockdown. Here, BAD is linked to acute myeloid leukemia.